Mega menu

Home
Product regulation
Product regulation

Understand your obligations and access industry Guidance and other information about the products we regulate.
Safety and shortages
Safety and shortages

Access information about product recalls, shortages and other alerts, and learn how we manage safety.
Resources and guidance
Resources and guidance

Get information to help you understand our work, regulations and industry obligations.
Business services
Business services

Access our systems to submit applications, manage forms, make payments and communicate securely.

Sun Pharma ANZ Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

ARTG (452)
Cancellation by sponsor (155)
Prescription medicine registration (29)
Section 14, TGO91 consent (5)
Australian public assessment report (AusPar) (4)
Prescription medicine decision summary (1)

Date

2026 (15)
2025 (40)
2024 (47)
2023 (36)
2022 (54)
2021 (42)
2020 (25)
2019 (26)
2018 (50)
2017 (18)
2016 (35)
2015 (20)
2014 (10)
2013 (22)
2012 (62)
2011 (92)
2010 (14)
2009 (13)
2007 (12)
2006 (10)
2005 (3)

Search

Sponsor content

646 result(s) found, displaying 351 to 360

VECURONIUM SUN vecuronium bromide 10mg powder for injection vial (223371)

28 April 2015

ARTG

Australian Register of Therapeutic Goods (ARTG) information for VECURONIUM SUN vecuronium bromide 10mg powder for injection vial.
EPOPROSTENOL SUN (Sun Pharma ANZ Pty Ltd)

3 July 2018

Prescription medicine registration

Active ingredients: Epoprostenol sodium.
TOPIRAMATE AN topiramate 50 mg tablets bottle Cancelled under Section 30(1)(c) of the Act

25 June 2018

Cancellation by sponsor

Requested by Sun Pharma ANZ Pty Ltd
NEVIRAPINE RBX nevirapine 200 mg tablets bottle pack Cancelled under Section 30(1)(c) of the Act

21 June 2018

Cancellation by sponsor

Requested by Sun Pharma ANZ Pty Ltd
CEFACLOR SUN CD cefaclor 375mg (as monohydrate) tablet blister pack Cancelled under Section 30(1)(c) of the Act

21 June 2018

Cancellation by sponsor

Requested by Sun Pharma ANZ Pty Ltd
LAMIVUDINE RBX lamivudine 150 mg tablet bottle Cancelled under Section 30(1)(c) of the Act

21 June 2018

Cancellation by sponsor

Requested by Sun Pharma ANZ Pty Ltd
LAMIVUDINE RBX lamivudine 300 mg tablet bottle Cancelled under Section 30(1)(c) of the Act

21 June 2018

Cancellation by sponsor

Requested by Sun Pharma ANZ Pty Ltd
RANCEF cefalexin 250mg capsule blister pack Cancelled under Section 30(1)(c) of the Act

18 June 2018

Cancellation by sponsor

Requested by Sun Pharma ANZ Pty Ltd
RANCEF cefalexin 500mg capsule blister pack Cancelled under Section 30(1)(c) of the Act

18 June 2018

Cancellation by sponsor

Requested by Sun Pharma ANZ Pty Ltd
OZVIR aciclovir 200mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

18 June 2018

Cancellation by sponsor

Requested by Sun Pharma ANZ Pty Ltd

Pages

First page
Previous page
…
Page 32
Page 33
Page 34
Page 35
Current page 36
Page 37
Page 38
Page 39
Page 40
…
Next page
Last page

Using our website

Accessibility
Privacy
Security
Disclaimer
Copyright
Freedom of information
Acronyms and glossary terms

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Email subscriptions
Contact us
Facebook
(formerly Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health, Disability and Ageing acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.